Reliance Pharma Fund (D)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 544.00
NAV 25 Sep 2017 54.66 -0.90
(-1.62%)

NAV High-Low (in Rs)

ONE Mth 1461.39
1461.39
52-WEEk 1235.15
1615.51

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 1.21 4.82 - - 3.41
Sensex -2.48 0.01 7.4 11.68 18.68
Nifty -2.72 0.15 8.38 13.17 23.88

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 544.00 (31 Dec 10)
Inception Date 10 May 04
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid 6.50 (Rs) 27-02-2017
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 Aug 2017
Category Share (%)
Cash & Cash Equivalent 0.00
CBLO 1.24
Derivatives 0.47
Equity 99.16
› More
   As On 31 Aug 2017
Sector Name Amount
Finance & Investments 2.72
Healthcare 13.58
NA 1.71
Pharmaceuticals - Indian - Bulk Drugs 16.23
Pharmaceuticals - Indian - Bulk Drugs & Formln 49.24
Pharmaceuticals - Multinational 17.39
› More
   As On 31 Aug 2017
Company Name
Aurobindo Pharma 9.93
Cipla 9.59
Divi's Lab. 9.53
Dr Reddy's Labs 9.28
Sun Pharma.Inds. 9.22
Abbott India 9.03
Sanofi India 8.36
Thyrocare Tech. 7.24
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com